Italia markets open in 4 hours 17 minutes

TEVA Aug 2024 16.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,63000,0000 (0,00%)
In data: 01:11PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,6300
Aperto0,6300
Denaro0,7500
Domanda0,9100
Prezzo d'esercizio16,50
Scadenza2024-08-02
Min-Max giorno0,6300 - 0,6300
Contratto - Min-MaxN/D
Volume7
Open Interest23
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.